Next Article in Journal
A New Phenolic Amide from the Roots of Paris verticillata
Next Article in Special Issue
Antiparkinson Prodrugs
Previous Article in Journal
Design and Synthesis of Novel N-Benzylidenesulfonohydrazide Inhibitors of MurC and MurD as Potential Antibacterial Agents
Previous Article in Special Issue
Synthesis of 1-Aryl-3-phenethylamino-1-propanone Hydrochlorides as Possible Potent Cytotoxic Agents
Molecules 2008, 13(1), 31-40; doi:10.3390/molecules13010031
Article

Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensis

1
, 1, 2, 2, 1, 3, 3, 4 and 1,*
Received: 2 November 2007; in revised form: 29 December 2007 / Accepted: 29 December 2007 / Published: 11 January 2008
(This article belongs to the collection Prodrugs)
Download PDF [221 KB, uploaded 18 June 2014]
Abstract: Two recently synthesized oxazolidinones: (R)-3-(4-(2-(2-methyltetrazol-5-yl)-pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (DA-7157) and itscorresponding pro-drug (R)-3-(4-(2-(2-methyltetrazol-5-yl)-pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidinyl) methyl disodium phosphate (DA-7218), have shown very goodactivity against several Gram positive bacteria, including Nocardia and Mycobacterium. Inthe present work we evaluated the therapeutic in vivo effects of DA-7218 on Nocardiabrasiliensis. We first determined the plasma concentration of the prodrug in BALB/c miceusing several doses and then tested its activity in an in vivo experimental actinomycetomamurine model. At the end of treatment, there was a statistically significant differencebetween the three drug receiving groups (25, 12.5 and 5 mg/kg) and the control group(saline solution) (p=0.001), proving that DA-7218 is effective for the treatment of experimental murine actinomycetoma. This compound could be a potential option forpatients affected with mycetoma by Nocardia brasiliensis.
Keywords: actinomycetoma; oxazolidinones; prodrug; Nocardia brasiliensis actinomycetoma; oxazolidinones; prodrug; Nocardia brasiliensis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Espinoza-González, N.A.; Welsh, O.; De Torres, N.W.; Cavazos-Rocha, N.; Ocampo-Candiani, J.; Said-Fernandez, S.; Lozano-Garza, G.; Choi, S.-H.; Vera-Cabrera, L. Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensis. Molecules 2008, 13, 31-40.

AMA Style

Espinoza-González NA, Welsh O, De Torres NW, Cavazos-Rocha N, Ocampo-Candiani J, Said-Fernandez S, Lozano-Garza G, Choi S-H, Vera-Cabrera L. Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensis. Molecules. 2008; 13(1):31-40.

Chicago/Turabian Style

Espinoza-González, Nelly A.; Welsh, Oliverio; De Torres, Noemi W.; Cavazos-Rocha, Norma; Ocampo-Candiani, Jorge; Said-Fernandez, Salvador; Lozano-Garza, Gerardo; Choi, Sung-Hak; Vera-Cabrera, Lucio. 2008. "Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensis." Molecules 13, no. 1: 31-40.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert